Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants

Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants

US Patent 12312613 · Granted May 27, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for increasing efficiency of nuclease-induced homology-directed repair2025
CRISPR-Cas enzymes with enhanced on-target activity2025
CRISPR-Cas enzymes with enhanced on-target activity2025
Engineered CRISPR-Cas9 nucleases with altered PAM specificity2025
Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf12025
Engineered CRISPR-Cas9 nucleases with altered PAM specificity2024
Variants of Cpf1 (Cas12a) with altered PAM specificity2024
Engineered CRISPR-Cas9 nucleases with altered PAM specificity2024
Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf12023
Engineered CRISPR-Cas9 nucleases with altered PAM specificity2023
Variants of Cpf1 (Cas12a) with altered PAM specificity2023
Engineered CRISPR-Cas9 nucleases with altered PAM specificity2022